195 related articles for article (PubMed ID: 38373256)
1. Histamine-3 Receptor Availability and Glutamate Levels in the Brain: A PET-1H-MRS Study of Patients With Schizophrenia and Healthy Controls.
Arumuham A; Nour MM; Veronese M; Beck K; Onwordi EC; Lythgoe DJ; Jauhar S; Rabiner EA; Howes OD
Int J Neuropsychopharmacol; 2024 Mar; 27(3):. PubMed ID: 38373256
[TBL] [Abstract][Full Text] [Related]
2. Intra-Regional Glu-GABA vs Inter-Regional Glu-Glu Imbalance: A 1H-MRS Study of the Neurochemistry of Auditory Verbal Hallucinations in Schizophrenia.
Hjelmervik H; Craven AR; Sinceviciute I; Johnsen E; Kompus K; Bless JJ; Kroken RA; Løberg EM; Ersland L; Grüner R; Hugdahl K
Schizophr Bull; 2020 Apr; 46(3):633-642. PubMed ID: 31626702
[TBL] [Abstract][Full Text] [Related]
3. Association of Age, Antipsychotic Medication, and Symptom Severity in Schizophrenia With Proton Magnetic Resonance Spectroscopy Brain Glutamate Level: A Mega-analysis of Individual Participant-Level Data.
Merritt K; McGuire PK; Egerton A; ; Aleman A; Block W; Bloemen OJN; Borgan F; Bustillo JR; Capizzano AA; Coughlin JM; De la Fuente-Sandoval C; Demjaha A; Dempster K; Do KQ; Du F; Falkai P; Galinska-Skok B; Gallinat J; Gasparovic C; Ginestet CE; Goto N; Graff-Guerrero A; Ho BC; Howes OD; Jauhar S; Jeon P; Kato T; Kaufmann CA; Kegeles LS; Keshavan M; Kim SY; Kunugi H; Lauriello J; Liemburg EJ; Mcilwain ME; Modinos G; Mouchlianitis ED; Nakamura J; Nenadic I; Öngür D; Ota M; Palaniyappan L; Pantelis C; Plitman E; Posporelis S; Purdon SE; Reichenbach JR; Renshaw PF; Russell BR; Sawa A; Schaefer M; Shungu DC; Smesny S; Stanley JA; Stone JM; Szulc A; Taylor R; Thakkar K; Théberge J; Tibbo PG; van Amelsvoort T; Walecki J; Williamson PC; Wood SJ; Xin L; Yamasue H
JAMA Psychiatry; 2021 Jun; 78(6):667-681. PubMed ID: 33881460
[TBL] [Abstract][Full Text] [Related]
4. The relationship between synaptic density marker SV2A, glutamate and N-acetyl aspartate levels in healthy volunteers and schizophrenia: a multimodal PET and magnetic resonance spectroscopy brain imaging study.
Onwordi EC; Whitehurst T; Mansur A; Statton B; Berry A; Quinlan M; O'Regan DP; Rogdaki M; Marques TR; Rabiner EA; Gunn RN; Vernon AC; Natesan S; Howes OD
Transl Psychiatry; 2021 Jul; 11(1):393. PubMed ID: 34282130
[TBL] [Abstract][Full Text] [Related]
5. Dopamine and Glutamate in Antipsychotic-Responsive Compared With Antipsychotic-Nonresponsive Psychosis: A Multicenter Positron Emission Tomography and Magnetic Resonance Spectroscopy Study (STRATA).
Egerton A; Murphy A; Donocik J; Anton A; Barker GJ; Collier T; Deakin B; Drake R; Eliasson E; Emsley R; Gregory CJ; Griffiths K; Kapur S; Kassoumeri L; Knight L; Lambe EJB; Lawrie SM; Lees J; Lewis S; Lythgoe DJ; Matthews J; McGuire P; McNamee L; Semple S; Shaw AD; Singh KD; Stockton-Powdrell C; Talbot PS; Veronese M; Wagner E; Walters JTR; Williams SR; MacCabe JH; Howes OD
Schizophr Bull; 2021 Mar; 47(2):505-516. PubMed ID: 32910150
[TBL] [Abstract][Full Text] [Related]
6. Altered glutamate level and its association with working memory among patients with treatment-resistant schizophrenia (TRS): a proton magnetic resonance spectroscopy study.
Huang LC; Lin SH; Tseng HH; Chen KC; Abdullah M; Yang YK
Psychol Med; 2023 May; 53(7):3220-3227. PubMed ID: 35197141
[TBL] [Abstract][Full Text] [Related]
7. The histamine system and cognitive function: An in vivo H3 receptor PET imaging study in healthy volunteers and patients with schizophrenia.
Arumuham A; Nour MM; Veronese M; Onwordi EC; Rabiner EA; Howes OD
J Psychopharmacol; 2023 Oct; 37(10):1011-1022. PubMed ID: 37329185
[TBL] [Abstract][Full Text] [Related]
8. Altered glutamatergic response and functional connectivity in treatment resistant schizophrenia: the effect of riluzole and therapeutic implications.
Pillinger T; Rogdaki M; McCutcheon RA; Hathway P; Egerton A; Howes OD
Psychopharmacology (Berl); 2019 Jul; 236(7):1985-1997. PubMed ID: 30820633
[TBL] [Abstract][Full Text] [Related]
9. The Relationships between Dopaminergic, Glutamatergic, and Cognitive Functioning in 22q11.2 Deletion Syndrome: A Cross-Sectional, Multimodal
van Hooijdonk CFM; Tse DHY; Roosenschoon J; Ceccarini J; Booij J; van Amelsvoort TAMJ; Vingerhoets C
Genes (Basel); 2022 Sep; 13(9):. PubMed ID: 36140839
[TBL] [Abstract][Full Text] [Related]
10. Glutamatergic Neurometabolite Levels in Patients With Ultra-Treatment-Resistant Schizophrenia: A Cross-Sectional 3T Proton Magnetic Resonance Spectroscopy Study.
Iwata Y; Nakajima S; Plitman E; Caravaggio F; Kim J; Shah P; Mar W; Chavez S; De Luca V; Mimura M; Remington G; Gerretsen P; Graff-Guerrero A
Biol Psychiatry; 2019 Apr; 85(7):596-605. PubMed ID: 30389132
[TBL] [Abstract][Full Text] [Related]
11. The association between
Beck K; Arumuham A; Brugger S; McCutcheon RA; Veronese M; Santangelo B; McGinnity CJ; Dunn J; Kaar S; Singh N; Pillinger T; Borgan F; Sementa T; Neji R; Jauhar S; Aigbirhio F; Boros I; Turkheimer F; Hammers A; Lythgoe D; Stone J; Howes OD
J Psychopharmacol; 2022 Sep; 36(9):1051-1060. PubMed ID: 36120998
[TBL] [Abstract][Full Text] [Related]
12. Glutamatergic basis of antipsychotic response in first-episode psychosis: a dual voxel study of the anterior cingulate cortex.
Fan L; Liang L; Wang Y; Ma X; Yuan L; Ouyang L; He Y; Li Z; Li C; Chen X; Palaniyappan L
Neuropsychopharmacology; 2024 Apr; 49(5):845-853. PubMed ID: 37752221
[TBL] [Abstract][Full Text] [Related]
13. Glutamate metabolites in treatment resistant schizophrenia: A meta-analysis and systematic review of
Kumar V; Manchegowda S; Jacob A; Rao NP
Psychiatry Res Neuroimaging; 2020 Jun; 300():111080. PubMed ID: 32279055
[TBL] [Abstract][Full Text] [Related]
14. Mania, glutamate/glutamine and risperidone in pediatric bipolar disorder: a proton magnetic resonance spectroscopy study of the anterior cingulate cortex.
Moore CM; Biederman J; Wozniak J; Mick E; Aleardi M; Wardrop M; Dougherty M; Harpold T; Hammerness P; Randall E; Lyoo IK; Renshaw PF
J Affect Disord; 2007 Apr; 99(1-3):19-25. PubMed ID: 17005256
[TBL] [Abstract][Full Text] [Related]
15. Decoupling of N-acetyl-aspartate and glutamate within the dorsolateral prefrontal cortex in schizophrenia.
Coughlin JM; Tanaka T; Marsman A; Wang H; Bonekamp S; Kim PK; Higgs C; Varvaris M; Edden RA; Pomper M; Schretlen D; Barker PB; Sawa A
Curr Mol Med; 2015; 15(2):176-83. PubMed ID: 25732147
[TBL] [Abstract][Full Text] [Related]
16. Glutathione and glutamate in schizophrenia: a 7T MRS study.
Kumar J; Liddle EB; Fernandes CC; Palaniyappan L; Hall EL; Robson SE; Simmonite M; Fiesal J; Katshu MZ; Qureshi A; Skelton M; Christodoulou NG; Brookes MJ; Morris PG; Liddle PF
Mol Psychiatry; 2020 Apr; 25(4):873-882. PubMed ID: 29934548
[TBL] [Abstract][Full Text] [Related]
17. Effects of N-acetylcysteine on brain glutamate levels and resting perfusion in schizophrenia.
McQueen G; Lally J; Collier T; Zelaya F; Lythgoe DJ; Barker GJ; Stone JM; McGuire P; MacCabe JH; Egerton A
Psychopharmacology (Berl); 2018 Oct; 235(10):3045-3054. PubMed ID: 30141055
[TBL] [Abstract][Full Text] [Related]
18. Functional magnetic resonance spectroscopy in patients with schizophrenia and bipolar affective disorder: Glutamate dynamics in the anterior cingulate cortex during a working memory task.
Jelen LA; King S; Horne CM; Lythgoe DJ; Young AH; Stone JM
Eur Neuropsychopharmacol; 2019 Dec; 29(2):222-234. PubMed ID: 30558824
[TBL] [Abstract][Full Text] [Related]
19. Increased glutamine in patients undergoing long-term treatment for schizophrenia: a proton magnetic resonance spectroscopy study at 3 T.
Bustillo JR; Chen H; Jones T; Lemke N; Abbott C; Qualls C; Canive J; Gasparovic C
JAMA Psychiatry; 2014 Mar; 71(3):265-72. PubMed ID: 24402128
[TBL] [Abstract][Full Text] [Related]
20. Brain glutamate concentration in men with early psychosis: a magnetic resonance spectroscopy case-control study at 7 T.
Godlewska BR; Minichino A; Emir U; Angelescu I; Lennox B; Micunovic M; Howes O; Cowen PJ
Transl Psychiatry; 2021 Jun; 11(1):367. PubMed ID: 34226485
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
